Day: July 26, 2021

BEIJING, July 26, 2021 (GLOBE NEWSWIRE) — Niu Technologies (“NIU”, or “the Company”) (NASDAQ: NIU), the world’s leading provider of smart urban mobility solutions, will release its financial results for the second quarter 2021 before the market opens on Monday, August 16, 2021. The corporate presentation and financials spreadsheets will be posted on NIU’s investor relations website at https://ir.niu.com/financial-information/quarterly-results. The Company will host an earnings conference call on Monday, August 16, 2021 at 8:00 AM U.S. Eastern Time (8:00 PM Beijing/Hong Kong Time) to discuss the financial and business results. To join via phone, participants need to register in advance of the conference call using the link provided below. Upon registration, participants will receive dial-in numbers, an event passcode, and a unique...

Cavotec has won a key order for its innovative motorised cable reel systems for integration onto advanced rail-mounted gantry cranes at the Port of Tokyo – a project that highlights Cavotec’s position as a trusted supplier of mission-critical systems at ports and terminals.  “Given the complexity of these high-end cranes and their demanding operational environment, this is an excellent reference for us as we continue to grow in Japan and the wider region,” says Robin Shang, Cavotec Regional Sales Director Ports & Maritime. Cavotec will supply motorised cable reel systems for eight automated rail-mounted gantry (ARMG) cranes at the Wan Hai Tokyo Oi5 terminal, a major global container handling hub. The cable reels will ensure the cranes meet demanding performance requirements due to surging container volumes.  Working closely with Chin...

Nasdaq CopenhagenLondon Stock ExchangeEuronext DublinOther stakeholders Date        26.07.2021 Share buy-back programme – week 29 The share buy-back programme runs from and including 4 February 2021 up to and including 30 July 2021. During this period Ringkjøbing Landbobank will buy-back shares to a maximum market value of DKK 255 million under a share buy-back programme, see company announcement of 3 February 2021. The programme is implemented in compliance with EU Commission Regulation No. 596/2014 of 16 April 2014 and EU Commission Delegated Regulation No. 2016/1052 of 8 March 2016, which together constitute the “Safe Harbour” regulation. The following transactions have been made under the programme:Date Number of shares Average purchase price (DKK) Total purchased under the programme (DKK)Total in accordance with the last...

Unaudited consolidated net profit of the INVL Baltic Farmland amounted to EUR 203 thousand for 6 months of 2021 and the revenue was EUR 320 thousand (for 6 months of 2020 consolidated net profit was EUR 165 thousand, revenue was EUR 307 thousand). Additional information: INVL Baltic Farmland, a company investing in agricultural land, has reported a revenue of EUR 320,000 and a net profit of EUR 203,000 in the first half of this year. Compared to the same period last year, the company’s revenue grew by 4.2%, while its net profit was up 23%. The company’s equity at the end of June stood at EUR 13.734 million. Equity per share was EUR 4.25, up 7% from a year earlier after taking into account the paid out dividend. „This year we are seeing consistently improving results of the company, driven by the successful year 2020 for farming activities...

Nanterre (France), July 26, 2021   Availability of the Financial report for the first half of 2021   Faurecia announces today that its Financial report for the first half of 2021 is available to the public and was filed with the French Autorité des marchés financiers.   It is available for consultation on the corporate website of the Company:   https://www.faurecia.com/en/investors/regulated-information/universal-registration-documents-half-year-results  Press contact Analysts/Investors contactEric Fohlen-Weill Director of Corporate Communication Tel.: +33 (0)1 72 36 72 58 eric.fohlen-weill@faurecia.com Marc Maillet Director of Investor Relations Tel.: +33 (0)1 72 36 75 70 marc.maillet@faurecia.com  About Faurecia Founded in 1997, Faurecia has grown to become a major player in the global automotive industry. With 266...

Lantern will reacquire global rights to Irofulven and assume full authority to manage and guide future clinical and commercial development of the programPress release Hørsholm, Denmark and Dallas, TX, U.S.A. (July 26, 2021) – Allarity Therapeutics A/S (“Allarity”) and Lantern Pharma Inc. (“Lantern”) today announced that they have entered into an exclusive agreement under which Lantern will reacquire global rights to Irofulven (“LP-100”) and assume full authority to manage and guide future clinical development and commercialization. Irofulven is a well-studied small molecule that causes bulky single strand DNA adducts that cause DNA damage in cancer cells, which can only be repaired by the transcription coupled nucleotide excision repair (TC-NER) pathway. This DNA modification stalls RNA polymerase II leading to transcription and cell...

Ad hoc announcement pursuant to Art. 53 LR Basel, Switzerland, July 26, 2021 Basilea Pharmaceutica Ltd. (SIX: BSLN) reported today that its partner Asahi Kasei Pharma Corporation (Asahi Kasei Pharma) is planning to file a New Drug Application (NDA) for the marketing authorization of the antifungal isavuconazole (Cresemba®) in Japan, based on the positive results of the recently completed phase 3 study in deep-seated mycoses. Asahi Kasei Pharma plans to publish topline results of the study at a later point in time. The phase 3, multi-center, open-label study enrolled 103 patients and was assessing the safety and efficacy of intravenously or orally administered isavuconazole for the treatment of adult Japanese patients suffering from deep-seated mycoses, including invasive aspergillosis, chronic pulmonary aspergillosis (CPA), mucormycosis...